approved

Приложение 4 на ПЛС от 02.03.2020 г.

Unique identificator:  cf27a960-59b5-4430-be4a-5bac8000c338

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-03-04 09:33:47
  • Created by: georgi_sivchev
  • Updated at: 2020-03-04 09:33:47
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Budesonide, Formoterol II-12855/ 17.04.2006 SYMBICORT TURBUHALER 320/9 MCG/INHALATION, Inhalation powder, 320 mcg/9 mcg/dose - 60 doses, IU, Pack: 1 AstraZeneca AB, Швеция AstraZeneca AB, Sweden; Corden Pharma GmbH, Germany 60.63 12.13 72.76 4% 2.43 63.06 12.61 75.67 16% 9.7 72.76 14.55 87.31 Отхвърлена жалба от Комисия по прозрачност с решение КП-17/17.02.2015 НСР-4749/02.10.2014 16.03.2015 16.03.2015 Неактивен 3615
Budesonide, Formoterol II-12855/ 17.04.2006 SYMBICORT TURBUHALER 320/9 MCG/INHALATION, Inhalation powder, 320 mcg/9 mcg/dose - 60 doses, IU, Pack: 1 AstraZeneca AB, Швеция AstraZeneca AB, Sweden; Corden Pharma GmbH, Germany 69.73 13.95 83.68 4% 2.79 72.52 14.5 87.02 16% 11.16 83.68 16.74 100.42 НСР-2283/13.01.2014 05.02.2014 05.02.2014 Неактивен 3615
Budesonide, Formoterol II-12855/ 17.04.2006 SYMBICORT TURBUHALER 320/9 MCG/INHALATION, Inhalation powder, 320 mcg/9 mcg/dose - 60 doses, IU, Pack: 1 AstraZeneca AB, Швеция AstraZeneca AB, Sweden; Corden Pharma GmbH, Germany 71.86 14.37 86.23 4% 2.87 74.73 14.95 89.68 16% 11.5 86.23 17.25 103.48 оттеглена жалба от Комисия по прозрачност с решение КП-180/10.04.2013 КЦРР-925/04.07.2012 24.04.2013 24.04.2013 Неактивен 3615
Budesonide, Formoterol II-12855/ 17.04.2006 SYMBICORT TURBUHALER 320/9 MCG/INHALATION, Inhalation powder, 320 mcg/9 mcg/dose - 60 doses, IU, Pack: 1 AstraZeneca AB, Швеция AstraZeneca AB, Sweden; Corden Pharma GmbH, Germany 79.43 15.89 95.32 4% 3.18 82.61 16.52 99.13 16% 12.71 95.32 19.06 114.38 КЦ-389/07.01.2009 26.01.2009 26.01.2009 Неактивен 3615
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat EU/1/17/1225/001 Symtuza, Film coated tablet, 800 mg/150 mg/200 mg/10 mg, -, Pack: 30 Janssen-Cilag International N.V., Белгия Janssen-Cilag SpA, Италия 1458.05 291.61 1749.66 4% 10 1468.05 293.61 1761.66 16% 25 1493.05 298.61 1791.66 НСР-20091/31.10.2019 Предварително изпълнение 31.10.2019 02.11.2019 Активен 16746
darunavir, cobicistat, emtricitabine and tenofovir alafenamide Symtuza, Film coated tablet, 800 mg/150 mg/200 mg/10 mg, -, Pack: 30 Janssen-Cilag International N.V., Белгия JanssenCilag SpA, Италия 1458.05 291.61 1749.66 4% 10 1468.05 293.61 1761.66 16% 25 1493.05 298.61 1791.66 НСР-20091/31.10.19 - с предварително изпълнение 31.10.2019 02.11.2019 Неактивен 16746
Palivizumab EU/1/99/117/001 Synagis, Powder and solvent for solution for injection, 50, mg, Pack: 1 AbbVie Ltd, Обединено Кралство AbbVie S.r.l, Campoverde di Aprilia(Latina), Италия 799.99 160 959.99 4% 10 809.99 162 971.99 16% 25 834.99 167 1001.99 НСР-7126/24.09.2015; НСР-9322/16.05.2016 02.07.2016 02.07.2016 Заличен 3109
Palivizumab EU/1/99/117/001 Synagis, Powder and solvent for solution for injection, 50, mg, Pack: 1 AbbVie Ltd, Обединено Кралство AbbVie S.r.l, Campoverde di Aprilia(Latina), Италия 799.99 160 959.99 4% 10 809.99 162 971.99 16% 25 834.99 167 1001.99 НСР-7126/24.09.2015 10.10.2015 10.10.2015 Неактивен 3109
Palivizumab EU/1/99/117/001 Synagis, Powder and solvent for solution for injection, 50, mg, Pack: 1 AbbVie Ltd, Обединено Кралство AbbVie S.r.l, Campoverde di Aprilia(Latina), Италия 837.27 167.45 1004.72 4% 10 847.27 169.45 1016.72 16% 25 872.27 174.45 1046.72 НСР-4321/05.08.2014 20.08.2014 20.08.2014 Неактивен 3109
Palivizumab EU/1/99/117/001 Synagis, Powder and solvent for solution for injection, 50, mg, Pack: 1 AbbVie Ltd, Обединено Кралство AbbVie S.r.l, Campoverde di Aprilia(Latina), Италия 851.43 170.29 1021.72 4% 10 861.43 172.29 1033.72 16% 25 886.43 177.29 1063.72 промяна на обстоятелства НСР-2664/03.02.2014- допуска предварителн изпълнение НСР-2812/21.02.2014 НСР-1645/11.11.2013 04.12.2013 04.12.2013 Неактивен 3109
Palivizumab EU/1/99/117/001 Synagis, Powder and solvent for solution for injection, 50, mg, Pack: 1 AbbVie Ltd, Обединено Кралство Abbot Laboratories S.r.l, Campoverde, Италия 913.43 182.69 1096.12 4% 10 923.43 184.69 1108.12 16% 25 948.43 189.69 1138.12 промяна на обстоятелства решение НСР-498/11.07.2013 КЦ-453/21.01.2009 12.02.2009 12.02.2009 Неактивен 3109
Palivizumab EU/1/99/117/003 Synagis, Solution for injection, 100 mg/ml, mg, Pack: 0.5 ml x 1 vial AbbVie Deutschland GmbH & Co. KG, Германия AbbVie S.r.l., Италия 789.06 157.81 946.87 4% 10 799.06 159.81 958.87 16% 25 824.06 164.81 988.87 Промяна на обстоятелствата НСР-16389/02.08.2018 НСР-5511/29.01.2015; НСР-10448/29.09.2016; НСР-15739/25.05.2018 09.06.2018 02.09.2018 Активен 3526
Palivizumab EU/1/99/117/003 Synagis, Solution for injection, 100 mg/ml, mg, Pack: 0.5 ml x 1 vial AbbVie Deutschland GmbH & Co. KG, Германия AbbVie S.r.l., Италия 789.06 157.81 946.87 4% 10 799.06 159.81 958.87 16% 25 824.06 164.81 988.87 Промяна на обстоятелствата НСР-16389/02.08.2018 НСР-5511/29.01.2015; НСР-10448/29.09.2016; НСР-15739/25.05.2018 09.06.2018 02.09.2018 Неактивен 3526
Palivizumab EU/1/99/117/003 Synagis, Solution for injection, 100 mg/ml, mg, Pack: 0.5 ml x 1 vial AbbVie Ltd, Обединено Кралство AbbVie S.r.l., Италия 789.06 157.81 946.87 4% 10 799.06 159.81 958.87 16% 25 824.06 164.81 988.87 НСР-5511/29.01.2015; НСР-10448/29.09.2016; НСР-15739/25.05.2018 09.06.2018 02.07.2018 Неактивен 3526
Palivizumab EU/1/99/117/003 Synagis, Solution for injection, 100 mg/ml, mg, Pack: 0.5 ml x 1 vial AbbVie Ltd, Обединено Кралство AbbVie S.r.l., Италия 796.82 159.36 956.18 4% 10 806.82 161.36 968.18 16% 25 831.82 166.36 998.18 НСР-5511/29.01.2015; НСР-10448/29.09.2016 14.10.2016 02.11.2016 Неактивен 3526
Palivizumab EU/1/99/117/003 Synagis, Solution for injection, 100 mg/ml, mg, Pack: 0.5 ml x 1 vial AbbVie Ltd, Обединено Кралство AbbVie S.r.l., Италия 837.27 167.45 1004.72 4% 10 847.27 169.45 1016.72 16% 25 872.27 174.45 1046.72 НСР-5511/29.01.2015 12.02.2015 12.02.2015 Неактивен 3526
Nafarelin II-14140/16.08.2006 Synarel, Nasal spray, solution, 2, mg, Pack: 8 Pfizer Europe MA EEIG, Обединено Кралство NPIL Pharmaceuticals (UK) Ltd. Morpeth Plant Whalton Road, Morpeth, Northumberland, NE61 3YA United Kingdom 218.13 43.63 261.76 4% 8.73 226.86 45.37 272.23 16% 25 251.86 50.37 302.23 Цената се заличава с решение НСР-2231/20.12.2013 КЦ-3173/04.11.2011 06.03.2013 06.03.2013 Заличен 1637
Nafarelin II-14140/16.08.2006 Synarel, Nasal spray, solution, 2, mg, Pack: 8 Pfizer Europe MA EEIG, Обединено Кралство NPIL Pharmaceuticals (UK) Ltd. Morpeth Plant Whalton Road, Morpeth, Northumberland, NE61 3YA United Kingdom 219.05 43.81 262.86 4% 8.76 227.81 45.56 273.37 16% 25 252.81 50.56 303.37 КЦ-707/09.03.2009 25.03.2009 25.03.2009 Неактивен 1637
Nafarelin II-14140/16.08.2006 Synarel, Nasal spray, solution, 2, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство NPIL Pharmaceuticals (UK) Ltd. Morpeth Plant Whalton Road, Morpeth, Northumberland, NE61 3YA United Kingdom 98.93 19.79 118.72 4% 3.96 102.89 20.58 123.47 16% 15.83 118.72 23.74 142.46 Цената се заличава с решение НСР-2231/20.12.2013 КЦ-3173/04.11.2011 06.03.2013 06.03.2013 Заличен 1636
Nafarelin II-14140/16.08.2006 Synarel, Nasal spray, solution, 2, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство NPIL Pharmaceuticals (UK) Ltd. Morpeth Plant Whalton Road, Morpeth, Northumberland, NE61 3YA United Kingdom 109.53 21.91 131.44 4% 4.38 113.91 22.78 136.69 16% 17.52 131.43 26.29 157.72 КЦ-707/09.03.2009 25.03.2009 25.03.2009 Неактивен 1636
Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated EU/1/09/508/003 Synflorix, Suspension for injection, Combination, съгл. посоченото съдържание в КХП, -, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals SA, Belgium 62.59 12.52 75.11 4% 2.5 65.09 13.02 78.11 16% 10.01 75.1 15.02 90.12 НСР-1281/25.09.2013 10.10.2013 10.10.2013 Неактивен 2958
Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated EU/1/09/508/003 Synflorix, Suspension for injection, Combination, съгл. посоченото съдържание в КХП, -, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals SA, Belgium 107.57 21.51 129.08 4% 4.3 111.87 22.37 134.24 16% 17.21 129.08 25.82 154.9 КЦ-883/18.05.2009 01.06.2009 01.06.2009 Неактивен 2958
Pneumococcal polysaccharide conjugate vaccine  (adsorbed) EU/1/ 09/508 /005 SYNFLORIX, Suspension for injection, 0.5, ml, Pack: 1 prefilled syringe + 2 needles GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Белгия 61.57 12.31 73.88 4% 2.46 64.03 12.81 76.84 16% 9.85 73.88 14.78 88.66 НСР-16866/28.09.2018 13.10.2018 02.11.2018 Активен 16291
Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated EU/1/ 09/508 /005 SYNFLORIX, Suspension for injection, 0.5, ml, Pack: 1 prefilled syringe + 2 needles GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Белгия 61.57 12.31 73.88 4% 2.46 64.03 12.81 76.84 16% 9.85 73.88 14.78 88.66 НСР-16866/28.09.2018 13.10.2018 02.11.2018 Неактивен 16291
Pneumococcal polysaccharide conjugate vaccine  (adsorbed) EU/1/09/508/003 SYNFLORIX, Suspension for injection, 0.5 ml, -, Pack: 1 pre-filled syringe + 1 needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals SA, Belgium 61.57 12.31 73.88 4% 2.46 64.03 12.81 76.84 16% 9.85 73.88 14.78 88.66 НСР-3842/16.06.2014 01.07.2014 01.07.2014 Активен 2958
Showing 14201 to 14226 of 17151 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте